2000至2021年比利时基层医疗焦虑登记趋势:基于注册研究
该回顾性队列研究利用比利时INTEGO发病率注册网络超60万患者数据,分析2000至2021年基层医疗焦虑的年龄标化患病率与发病率趋势、共病及治疗。结果显示焦虑患病率从1.1%升至4.8%,发病率从1.1/1000患者年升至9.9/1000患者年,患者慢性病数从1.5增至2.3,精神药物使用比例从25.7%升至近40%。
要点
- 焦虑患病率与发病率在22年间显著上升,患病率从1.1%升至4.8%。
- 焦虑患者共病负担加重,平均慢性病数从1.5增至2.3。
- 精神药物治疗比例从25.7%升至近40%,治疗高度依赖药物。
核心结论
- 比利时基层医疗中医生登记的焦虑患病率和发病率显著增加,焦虑患者趋于更复杂且共病更多,治疗高度依赖药物。
研究设计与样本
- 回顾性队列研究,使用INTEGO发病率注册网络,纳入比利时弗兰德斯地区超60万患者的临床数据,研究期为2000至2021年。
主要发现
- 22年间共识别8451例焦虑患者,患病率从2000年1.1%升至2021年4.8%。
- 总体发病率从2000年1.1/1000患者年升至2021年9.9/1000患者年。
- 每例患者平均慢性病数从1.5显著增至2.3。
- 2017-2021年焦虑患者最常见共病为恶性肿瘤(20.1%)、高血压(18.2%)和肠易激综合征(13.5%)。
- 接受精神药物治疗的患者比例从25.7%升至近40%。
临床怎么用
- 基层医生应关注焦虑患病率上升趋势,对焦虑患者常规评估共病尤其是恶性肿瘤、高血压和肠易激综合征。
- 鉴于治疗高度依赖药物,临床应重视综合管理及非药物干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anxiety is frequently encountered in general practice, but figures regarding prevalence and incidence in this healthcare setting remain scarce. AIM: To provide insight about the trends in prevalence and incidence of anxiety in Belgian general practice, as well as the comorbidities and treatment of anxiety in this context. DESIGN AND SETTING: Retrospective cohort study using the INTEGO morbidity registration network, with clinical data from over 600 000 patients in Flanders, Belgium. METHOD: Trends in age-standardised prevalence and incidence of anxiety from 2000 to 2021 as well as prescriptions in patients with prevalent anxiety were analysed with joinpoint regression. Comorbidity profiles were analysed using the Cochran-Armitage test and the Jonckheere-Terpstra test. RESULTS: During the 22-year study period, 8451 unique patients with anxiety were identified. The prevalence of anxiety diagnoses rose significantly during this period, from 1.1% in 2000 to 4.8% in 2021. The overall incidence rate rose from 1.1/1000 patient-years (PY) in 2000 to 9.9/1000 PY in 2021. The average chronic disease count per patient increased significantly during the study period, from 1.5 to 2.3 chronic conditions. The most frequent comorbidities in patients with anxiety in 2017-2021 were malignancy (20.1%), hypertension (18.2%), and irritable bowel syndrome (13.5%). The proportion of patients treated with psychoactive medication rose from 25.7% to almost 40% over the study period. CONCLUSION: A significantly increasing prevalence and incidence of physician-registered anxiety was found in the study. Patients with anxiety tend to become more complex, with more comorbidities. Treatment for anxiety in Belgian primary care is very dependent on medication.
引用
- Beerten SG, Coteur K, Mamouris P, et al. Trends in the registration of anxiety in Belgian primary care from 2000 to 2021: a registry-based study. Br J Gen Pract. 2023. PMID: 37230771. doi:10.3399/BJGP.2022.0196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。